Submit Abstract / Manuscript

Please click "SUBMIT" below


FSCDR's 18th Annual Sickle Cell Disease Research and Educational Symposium and 47th National Sickle Cell Disease Scientific Meeting

June 7 - 9, 2024

Submission & Notification Deadlines:

Abstract Scorecard Site opens- January 8, 2024

Abstract Scorecard Site closes for general submissions- February 19, 2024
Notifications sent out- March 11, 2024

Late-breaking abstract submission deadline- April 1, 2024
Late-breaking notifications sent out- April 22, 2024

This website also serves as the submission location for the Grant Writing Institute Grant submissions. If you are submitting a grant for review, please select the “Grant Writing Institute” option once you are logged in

Accepted submissions are published on the first day of the symposium you are submitting for. For example, if the symposium is June 7 – June 9, 2024 the Journal of Sickle Cell Disease and Hemoglobinopathies publication date is June 7, 2024.

Santosh Saraf, MD

Scientific Chair

Dr. Santosh L. Saraf received his medical degree from the Temple University School of Medicine and completed an internal medicine residency and hematology & oncology fellowship at the University of Illinois at Chicago (UIC). Dr. Saraf joined the Division of Hematology & Oncology at UIC in 2012 and completed a Master of Science in Clinical and Translational Research through the University of Illinois School of Public Health in 2014. He currently serves as the Director of Translational Research for the Sickle Cell Center and the Fellowship Program Director for Hematology & Oncology. Dr. Saraf focuses his clinical care and research on understanding the mechanisms of kidney disease in patients with sickle cell disease and on developing curative therapies through hematopoietic stem cell transplantation for patients with clinically aggressive sickle cell disease.

Alan Anderson, MD

Scientific Co-Chair

Dr. Anderson is an Associate Professor of Clinical Pediatrics at the University of South Carolina School of Medicine in Greenville, SC. He completed his pediatric residency at the Medical University of SC in Charleston, SC and pediatric hematology/oncology fellowship training at Emory University. He is the director of the Comprehensive “Lifespan” Sickle Cell Disease Program at Prisma Health-Upstate in Greenville, SC. His program provides care for over 450 individuals with sickle cell disease and includes services for patients of all ages within the same dedicated clinical space. Dr. Anderson is involved in both cooperative and industry-sponsored research trials for SCD and his program is part of the American Society of Hematology SCD Clinical Trials Network (ASH SCD-CTN). In addition to his work in the United States, Dr. Anderson partners with clinicians in W. Africa to establish newborn screening programs for SCD. He believes strongly in engaging the voice of the patient and the community in all aspects of care.